title: The optimal MMF dose in tacrolimus treated patients.
authors.affiliation: Department of Pharmacy, Erasmus MC, Rotterdam, the Netherlands; Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands.
authors.forename: T
authors.initials: T
authors.lastname: van Gelder
authors.forename: R
authors.initials: R
authors.lastname: Bouamar
authors.forename: N
authors.initials: N
authors.lastname: Shuker
authors.forename: D
authors.initials: D
authors.lastname: Hesselink
authors.forename: W
authors.initials: W
authors.lastname: Weimar
authors.forename: B
authors.initials: B
authors.lastname: Kaplan
authors.forename: C
authors.initials: C
authors.lastname: Bernasconi
mesh_terms: D005260:Female; D006084:Graft Rejection / Q000401:mortality*; D006801:Humans; D008107:Liver Diseases / Q000601:surgery*; D016031:Liver Transplantation / Q000401:mortality*; D008297:Male; D011183:Postoperative Complications; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000706:statistics & numerical data*